ARCT - Arcturus Therapeutics GAAP EPS of -$1.00 beats by $0.23 revenue of $38M beats by $20.33M May, 08 2024 04:03 PM Arcturus Therapeutics Ltd. 2024-05-08 16:03:45 ET More on Arcturus Therapeutics Arcturus Therapeutics' ARCT-032: Might Be The Next Breakthrough In Cystic Fibrosis As more rare disease therapies launch, their prices are rising Seeking Alpha’s Quant Rating on Arcturus Therapeutics For further details see: Arcturus Therapeutics GAAP EPS of -$1.00 beats by $0.23, revenue of $38M beats by $20.33M